Two Sigma Investments »

Neuropace shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $199k 19k 10.31
2025-06-30 $987k 89k 11.14
2025-03-31 $399k 32k 12.29
2024-12-31 $293k 26k 11.19
2024-06-30 $250k 33k 7.56

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
OrbiMed Advisors
BlackRock
Vanguard Group
First Light Asset Management
Armistice Capital
Kent Lake PR
Driehaus Capital Management
Deutsche Bank Aktiengesellschaft
FMR
Geode Capital Management
State Street Corporation
Silvercrest Asset Management Group
Nantahala Capital Management

View all funds holding Neuropace